Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)
皮疹剂量:一线厄洛替尼治疗晚期非小细胞肺癌患者的 II 期试验——东部肿瘤协作组研究 (E3503)
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2013.10.006
Brahmer, J R; Lee, J W; Traynor, A M; Hidalgo, M M; Kolesar, J M; Siegfried, J M; Guaglianone, P P; Patel, J D; Keppen, M D; Schiller, J H